Short answer
Guardian Pharmacy Services, Inc. (GRDN) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $371M (down 1.7% year over year) with net income of $19M.
Q3 2026 key financials · XBRL
- Revenue
- $371M
- −1.7% YoY · +5.5% QoQ
- Net income
- $19M
- +90.3% YoY · −14.6% QoQ
- Operating margin
- 6.8%
- Gross margin
- 23.0%
- EPS (diluted)
- $0.84
Source: XBRL data from the Guardian Pharmacy Services, Inc. (GRDN) Q3 2026 10-Q on SEC EDGAR. USD.
Guardian Pharmacy Services, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $371.1M, down 1.7% from $377.4M, reflecting IRA-related pricing reductions
- Gross margin 23.0% vs 19.8%; net margin 5.2% vs 2.5% YoY
- Acquisitions strongest contributor, adding $7.3M revenue; organic revenue decreased $13.7M
- Cash $119.7M; nine-month operating cash flow $79.5M vs $65.7M, up $13.8M
- IRA price reductions remain a headwind, expected to affect year-over-year comparability through the remainder of 2026
Risk Factors
- No material changes to risk factors since the December 31, 2025 Form 10-K
- Regulatory risk: existing 10-K risks remain applicable to pharmacy operations
- Operational risk: carried-forward 10-K risks could adversely affect business and results
- Financial risk: existing 10-K risks could adversely affect financial condition and prospects
- Market risk: carried-forward risks could reduce Class A common stock price
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Guardian Pharmacy Services, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.